||

21st SoGAT Meeting

SoGAT XX1 Presentations

 

Speaker

Title of Talk

Presentation

Isabelle Thomas, IPH, Belgium The importance on the surveillance of Influenza viruses
Ana Padilla, WHO, Switzerland Review of WHO Collaborating Centres meeting, 17-19 February 2009
Sally Baylis Replacement International Standard for B19

Anne Op de beeck, M Draps, S Baurin, P Caillet-Fauquet, Ruth Laub

Active B19 virions production in hepatoblastoma and hepatocarcinoma cell lines: amplification and genomic stability
Mei-ying Yu (jointly with S Baylis) Current status of B19V NAT screening in the U.S. and the preparation of 4-member genotype panel
Theo Cuypers, M Koppelman Dual testing with quantitative Parvo B19 DNA assays; genotype recognition and isolates with mismatches
Rob Anderson Plans for HAV genotype panel
Micha Nuebling Yield obtained by mandatory HCV- and HIV1-NAT in Germany and break-through transmissions
Richard Tedder Role for HCV antigen detection: a new generation of assays
Isabel Micalessi, I Thomas, B Brochier Hepatitis E in Belgium: an import infection or an emerging viral zoonosis?
Sally Baylis Proposal to prepare standards and reference panels for hepatitis E virus
Samreen Ijaz, R Eglin, M Beale, R Tedder Indigenous HEV infection in the UK: a hazard for blood donation?
Indira Hewlett Update on CBER HIV CRF02_AG and 01_ AE NAT panels and international HIV panel development efforts
Mark Manak Preparation of reference panels for current and emerging HIV variants
Harvey Holmes Development of HIV-2 International standard
Lutz Pichl Experiences with Roche Cobas s 201 in routine minipool screening (HCV, HIV, HBV)
Ralf Schoenbrunner SynTura: A new Ribonuclease resistant viral RNA control material
Thomas Montag-Lessing ISBT International Validation Study on Transfusion-relevant Bacterial Strain Panel
Ineke Rood, D de Korte, A Pettersson, P Savelkoul Development of a real time RT-PCR assay for broad range detection of bacteria in platelet concentrates
Francesca Luciani The Italian NAT External Quality Assessment Study: the 2008 Programme
Saeko Mizusawa NAT proficiency program in Japan
Clare Morris HIV-1 NAT proficiency study for UK BTS
Julia Kress Proficiency Testing of in-house NAT assays used for Blood Screening
Karen Cristiano Calibration Against The WHO Standards Of National Reference Preparations For Detection Of Blood Viruses By NAT: The Italian Experience
Harry van Drimmelen A multi-centre evaluation study of different run and trend control samples
Yi-Chen Yang National standards for blood viruses in Taiwan
Ewa Brojer The effect of NAT sensitivity on the yield of HBV DNA, HCV RNA and HIV RNA detection in seronegative donations
Jacqueline Fryer Standardising NAT for other clinical targets through SoGAT Clinical Diagnostics
Jacqueline Fryer An update on the development of proposed 1st WHO International Standards for human cytomegalovirus and Epstein-Barr virus
Michael Chudy Development of HBV genotype reference panels for NAT assays and for HBsAg tests
Daniel Candotti Correlation between HBsAg and HBV genome concentrations according to genotype
Wolfram Gerlich Calibration of International HBsAg Units in ng/ml for HBV genotypes A-H and comparison with HBV DNA levels
Marco Koppelman Comparison of HBV NAT in small test pools versus large pools: experience with the S201 system
Heiner Scheiblauer Establishment of 1st WHO International Standard for anti-HBc
John Saldanha Screening for HBV/HBc in USA
Richard Tedder Epitope profiling from HBsAg plasma
Penelope Garmiri HBV genotypes E and A deletions and recombinations: two sides of the same coin?
Wolfram Gerlich Stability of HBV DNA in reference preparations